Supporting innovation from lab to market across the Asia-Pacific
Why intellectual property matters
Life sciences and biotechnology companies operate in a fast-moving, high-stakes environment where protecting innovation is critical. Whether you’re developing new therapeutics, diagnostics, agricultural solutions, or industrial biotech applications, securing your IP early and strategically can:
- safeguard proprietary technologies and data
- attract investment and commercial partnerships
- enable global expansion and licensing opportunities
- mitigate competitive risks and regulatory challenges.
Regional expertise, global perspective
Spruson & Ferguson has a long-established practice assisting clients in the biotech, pharmaceutical and life sciences sectors across the Asia-Pacific. We have local teams in key jurisdictions including Australia, Singapore, China, Hong Kong, New Zealand, Indonesia, Philippines, Thailand, and Malaysia.
For clients facing disputes or litigation in Australia, or looking to commercialise their innovations, our litigation and commercialisation teams at Spruson & Ferguson Lawyers are highly specialised and experienced in guiding and assisting organisations through all of these aspects.
Your key relationship manager will act as a partner to your team, and our integrated approach to innovation protection across these life sciences sectors ensures:
- seamless multi-jurisdictional filings and prosecution
- strategic advice tailored to regional regulatory frameworks
- efficient coordination across borders for complex portfolios.
Who we work with
We provide tailored services to life sciences and biotech innovators at every stage of growth, such as:
- Startups & spinouts – IP strategy development, patent drafting, freedom-to-operate analysis
- Established national and multinational biotech and pharmaceutical firms – Portfolio management, patent prosecution and enforcement services including running litigation, licensing and commercialisation support
- Universities & research institutes – Commercialisation support, patent drafting and prosecution services
- Investors & corporate counsel – Due diligence and risk assessment advice, IP audits
Our Life Sciences and Biotech capabilities
We understand the science and can translate this knowledge into robust and commercially valuable IP.
Our expert team includes patent attorneys and technical specialists with advanced degrees including in:
- molecular biology, genetics, immunology, biochemistry
- physiology, neuroscience, oncology, virology, microbiology, molecular biology
- agricultural and environmental biotechnology
- industrial biotech and synthetic biology
- synthetic organic and pharmaceutical chemistry
- pharmaceuticals, biologics, and medical diagnostics.
In Australia, our patent and trade mark attorneys work alongside commercialisation experts and the highly experienced specialist litigators in our law firm, Spruson & Ferguson Lawyers. These lawyers have successfully represented clients in some of Australia’s largest pharmaceutical litigation matters. For more information, head to our Intellectual Property Law page.
Services overview
Among our IP services for life sciences, pharmaceutical and biotech clients, are patent term extensions – particularly in Australia. Find out more about how we help clients to protect and leverage their IP below.
-
Protection
- Patent drafting and prosecution
- Patentability and freedom to operate searches
- Opposition and litigation support
- Patent portfolio strategy and management
-
Strategy
- Regional filing strategies
- Expedited filing pathways
- Regional portfolio management
-
Commercialisation
- IP due diligence for investment and M&A
- Licensing and technology transfer
- Market entry and regulatory alignment
- Strategic advice for global expansion
-
Enforcement
- Dispute resolution
- Litigation
- Validity and infringement opinions
-
Patent Term Extensions
Pharmaceutical patent term extensions (PTEs) provide innovators with additional years of patent life to offset time lost in developing and obtaining regulatory approval for new pharmaceutical substances.
Four key jurisdictions across APAC provide the ability to extend patent life by up to five years.
Each jurisdiction has their own legal requirements regarding eligibility, so for further detail, please reach out to one of our experts operating in the region of your interest.
- Australia – Over the last 10 years, our experts have successfully secured over 200 PTEs for our clients – almost double that of any other IP firm in Australia. We are well versed in the requirements and keen to assist you as well.
- China
- Singapore
- Taiwan
Why clients choose us
While we let our results speak for themselves, clients consistently value:
- sector-specific insight – we speak their language fluently
- regional depth – local knowledge across the Asia Pacific, with global insights
- commercial focus – IP strategies aligned with business goals
- collaborative approach – we work as an extension of your team.
Let’s talk
Whether you’re protecting a breakthrough or scaling globally, Spruson & Ferguson is ready to support your journey.
Our latest sector articles are below for your interest. Reach out to discuss how we can tailor our services to your needs.